enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The popular weight-loss drug Zepbound can now be used to ...

   www.aol.com/news/popular-weight-loss-drug-zep...

   The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

3. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug-zep...

   By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted ...

4. FDA approves weight-loss drug Zepbound for obstructive sleep ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   The FDA approval for sleep apnea is based on two company-sponsored trials encompassing about 470 participants, one in which patients were being treated with continuous positive air pressure, or ...

5. Hypoglossal nerve stimulator - Wikipedia

   en.wikipedia.org/wiki/Hypoglossal_nerve_stimulator

   Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]

6. Vivos Therapeutics Schedules Release of Third Quarter 2024 ...

   lite.aol.com/tech/story/0022/20241113/9273434.htm

   LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults), today ...

7. FDA approves Eli Lilly’s obesity medication for obstructive ...

   www.aol.com/news/fda-approves-eli-lilly-obesity...

   The new approval is for people with moderate to severe obstructive sleep apnea who are also living with obesity. Eli Lilly estimates that is about 15-20 million adults in the U.S.